{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:02:56Z","timestamp":1768482176729,"version":"3.49.0"},"reference-count":114,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2021,1,22]]},"DOI":"10.1080\/14656566.2020.1817386","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T17:06:12Z","timestamp":1599843972000},"page":"167-177","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":30,"title":["Therapeutic options for difficult-to-treat A<i>cinetobacter baumannii<\/i>infections: a 2020 perspective"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2004-3724","authenticated-orcid":false,"given":"Matteo","family":"Bassetti","sequence":"first","affiliation":[{"name":"Clinica Malattie Infettive, Ospedale Policlinico San Martino \u2013 IRCCS, Genoa, Italy"},{"name":"Department of Health Sciences, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Labate","sequence":"additional","affiliation":[{"name":"Clinica Malattie Infettive, Ospedale Policlinico San Martino \u2013 IRCCS, Genoa, Italy"},{"name":"Department of Health Sciences, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Russo","sequence":"additional","affiliation":[{"name":"Clinica Malattie Infettive, Ospedale Policlinico San Martino \u2013 IRCCS, Genoa, Italy"},{"name":"Department of Health Sciences, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Vena","sequence":"additional","affiliation":[{"name":"Clinica Malattie Infettive, Ospedale Policlinico San Martino \u2013 IRCCS, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele Roberto","family":"Giacobbe","sequence":"additional","affiliation":[{"name":"Clinica Malattie Infettive, Ospedale Policlinico San Martino \u2013 IRCCS, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00058-07"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz505"},{"key":"cit0003","first-page":"1803","volume":"67","author":"Kadri SS","year":"2018","journal-title":"Clin Infect Dis"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1694002"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2017.148"},{"key":"cit0006","unstructured":"FDA Drug Safety Communication. FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning. [cited 2020 Jun 27]. Available from: https:\/\/www.fda.gov\/drugs\/drugsafety\/ucm369580.htm."},{"key":"cit0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji BT","year":"2019","journal-title":"Pharmacotherapy"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.2.545"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1549487"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.05.017"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ048"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30361-5"},{"key":"cit0013","volume":"33","author":"De Oliveira DMP","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2017.1344235"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-019-0706-5"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00704-11"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks448"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00117-13"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2016.0152"},{"key":"cit0020","volume":"5","author":"Hamidian M","year":"2019","journal-title":"Microb Genom"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00899-09"},{"key":"cit0022","volume":"63","author":"Yang Y","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02380-08"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.5.1681-1688.2003"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr364"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00155-10"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.3201\/eid2404.171461"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3375-3380.2001"},{"key":"cit0029","first-page":"72","volume":"14","author":"Shrestha S","year":"2016","journal-title":"J Nepal Health Res Counc"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01405-08"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00256-11"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00079-11"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00515-15"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00834-10"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz413"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.06.009"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2070-6"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1916-6"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00494-15"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-72-6-857"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03734.x"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit253"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.02061.x"},{"key":"cit0044","first-page":"3291","volume":"70","author":"Cheah SE","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01733-10"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00554-15"},{"key":"cit0047","first-page":"565","volume":"64","author":"Nation RL","year":"2017","journal-title":"Clin Infect Dis"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30099-9"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000000653"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw353"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.04.011"},{"key":"cit0052","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7060159","volume":"7","author":"Fragkou PC","year":"2019","journal-title":"Microorganisms"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.11.011"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1186\/cc13858"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1186\/cc13942"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8395268"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2016.1193789"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.05.002"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2014.995129"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2013(04)21"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn128"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1717-6"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx368"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz827"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-1055-2"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-009-9219-2"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz825"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.09.001"},{"key":"cit0069","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijantimicag.2018.10.007","volume":"53","author":"Kazmierczak KM","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"cit0070","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00093-17","volume":"61","author":"Hackel MA","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"cit0071","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jac\/dky425","volume":"74","author":"Hsueh SC","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03098-15"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01695-15"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00286-6"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30554-1"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2019.1680283"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz415.2487"},{"key":"cit0078","unstructured":"Matsunaga Y, Echols R, Katsube Tet al. Cefiderocol (S-649266) for Nosocomial Pneumonia Caused by Gram-Negative Pathogens: study Design of APEKS-NP, a Phase 3 Double-Blind Parallel-Group Randomized Clinical Trial. In: B42. CRITICAL CARE: THE FEVER - INFECTIONS IN THE ICU. American Thoracic Society; 2018. pp. A3290\u2013A3290."},{"key":"cit0079","unstructured":"Shionogi Inc. Briefing Information for the october 16, 2019 meeting of the antimicrobial drugs advisory committee [cited 2020 Jul 4]. Available from: https:\/\/www.fda.gov\/media\/131705\/download."},{"key":"cit0080","unstructured":"Shionogi Inc. FDA accepts shionogi\u2019s supplemental new drug application with priority review for FETROJA\u00ae (cefiderocol) for the Treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia [cited 2020 Jul 4]. Available from: https:\/\/www.shionogi.com\/us\/en\/news\/2020\/6\/FDA-Accepts-Shionogis-Supplemental-New-Drug-Application-with-Priority-Review-for-FETROJA.html."},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S225553"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz829"},{"key":"cit0083","unstructured":"EMA\/CHMP\/73102\/2020. Committee for Medicinal Products for Human Use (CHMP). Summary of opinion (initial authorisation). Fetcroja (cefiderocol) [cited 2020 Jul 4]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/smop-initial\/chmp-summary-positive-opinion-fetcroja_en.pdf."},{"key":"cit0084","unstructured":"Fectroja. Summary of product characteristics [cited 2020 Jul 5]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/fetcroja-epar-product-information_en.pdf."},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00074"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.06.022"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01288-13"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.4237"},{"key":"cit0089","unstructured":"Tetraphase Pharmaceuticals. Tetraphase announces top-line results from IGNITE3 phase 3 clinical trial of eravacycline in complicated urinary tract infections (cUTI) [cited 2020 Jul 4]. Available from: http:\/\/ir.tphase.com\/news-releases\/news-release-details\/tetraphase-announces-top-line-results-ignite3-phase-3-clinical."},{"key":"cit0090","unstructured":"Tetraphase Pharmaceuticals. Tetraphase announces top-line results from IGNITE2 phase 3 clinical trial of eravacycline in cUTI [cited 2020 Jul 4]. Available from: https:\/\/ir.tphase.com\/news-releases\/news-release-details\/tetraphase-announces-top-line-results-ignite2-phase-3-clinical."},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1029"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2366"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801467"},{"key":"cit0094","unstructured":"Zemdri. Prescribing information. [cited 2020 Jul 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210303Orig1s000lbl.pdf."},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00873-15"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq459"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02744-13"},{"key":"cit0098","unstructured":"Withdrawal letter: zemdri [cited 2020 Jul 4]. Available at: https:\/\/www.ema.europa.eu\/documents\/withdrawal-letter\/withdrawal-letter-zemdri_en.pdf."},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.104"},{"key":"cit0100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01576-17","volume":"62","author":"McLeod SM","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0340-0"},{"key":"cit0102","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00159-19","volume":"10","author":"Barnes MD","year":"2019","journal-title":"mBio"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04808-14"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.9b00217"},{"key":"cit0105","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00935-19","volume":"63","author":"Akhoundsadegh N","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa217"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.03.009"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.10.010"},{"key":"cit0109","volume":"64","author":"Lomovskaya O","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"cit0110","volume":"61","author":"Moya B","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00091"},{"key":"cit0112","unstructured":"World Health Organization. 2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline [cited 2020 Jul 5]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/330420\/9789240000193-eng.pdf."},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01326-19"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa355"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2020.1817386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T23:43:45Z","timestamp":1668728625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2020.1817386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,22]]}},"alternative-id":["10.1080\/14656566.2020.1817386"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2020.1817386","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}